Cybn stock chart
Web2 days ago · Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced the launch of EMBARK Open Access (“EMBARK OA”), a free online foundational training … Web2 days ago · Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental …
Cybn stock chart
Did you know?
WebCybin Inc (CYBN) My Charts Alerts Watch Help Go To: Interactive Chart Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom spreads and expressions, plus a wide range of visualization tools. WebThe CYBN stock price is closed at $ 0.382300 with a total market cap valuation of $ 72.34M ( 44M shares outstanding). The CYBN is trading on AMEX with the sign CYBN. CYBN …
WebApr 12, 2024 · Apr. 12, 2024, 05:31 PM. This article Cybin Offers Free Online Training To Facilitate Psychedelic Therapy originally appeared on Benzinga.com. Read more on "Benzinga". WebStock analysis for Cybin Inc (CYBN:NEO-L Lit) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebMar 30, 2024 · Cybin Inc. Common Shares (CYBN) Stock Price, Quote, News & History Nasdaq Cybin Inc. Common Shares (CYBN) No Notifications Add to Watchlist Add to Portfolio Quotes Jan 10, 2024 4:47 PM ET... WebAug 9, 2024 · For instance, Cybin. Sellers rejected the stock at $3.40 a little more than a week ago. Since then, we have five straight red days, shares falling under the 21-day simple moving average (SMA ...
WebCybin Inc -- -- -- -- 14.06% -19.46% -75.24% 29.59% S&P 500 Total Return 11.96% 21.83% -4.38% 31.49% 18.40% 28.71% -18.11% 7.50% Tilray Brands Inc 310.7% 292.3% -61.42% -8.26% 32.57% -14.86% -61.74% -5.58% Aurinia Pharmaceuticals Inc -14.98% 115.7% 50.55% 197.1% -31.74% 65.37% -81.11% 153.5% Edesa Biotech Inc -68.72% -60.09% …
WebCybin (CYBN) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... CYBN Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 - $0. 52-Week Range $0.26 - $1.14. Previous Close $0.39. Volume 731.53K. Average Volume … red buzz wholesajjeWebAdvanced Charting News Cybin Inc. Significant News Only No significant news for CYBN in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.22 Market Cap … red buuWeb20 hours ago · About CYBN. Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline … red buzzer button onlineWebThe chart at the top shows a one-year chart for the symbol, with Earnings highlighted. Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. Historical Ratings. The table shows the mean historical analyst recommendation for the current period, along with the previous 1, 2, and 3 periods. red buttons wifeWebMar 18, 2024 · Analysts expect CYBN’s EPS to come in at a negative $0.08 for the fiscal quarter ending March 2024. CYBN’s stock has gained 4.8% in price over the past five days and 1.2% intraday to close yesterday’s trading session at $0.84. Of the two Wall Street analysts rating CYBN, one has rated it Buy, while one has rated it Hold. red buzzer buttonWebCreate advanced interactive price charts for CYBN, with a wide variety of chart types, technical indicators, overlays, and annotation tools. CYBN SharpCharts … knicks vs heat highlightsWebSee CYBIN INC. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... No trades. See on super-charts. Overview News Ideas Financials Technicals . Forecast . Price target. 6.58 0.00 0.00%. The 6 analysts offering 1 year price forecasts for CYBN have a max estimate of ... knicks vs heat injury report